Published in BMC Bioinformatics on July 15, 2005
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotechnol (2014) 2.19
Beyond Affymetrix arrays: expanding the set of known hybridization isotherms and observing pre-wash signal intensities. Nucleic Acids Res (2009) 1.54
Methodological study of affine transformations of gene expression data with proposed robust non-parametric multi-dimensional normalization method. BMC Bioinformatics (2006) 1.26
Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients. Pharmacogenomics J (2010) 1.21
Review of the literature examining the correlation among DNA microarray technologies. Environ Mol Mutagen (2007) 1.14
Improvement in the reproducibility and accuracy of DNA microarray quantification by optimizing hybridization conditions. BMC Bioinformatics (2006) 1.12
The end of the microarray Tower of Babel: will universal standards lead the way? J Biomol Tech (2006) 1.11
A competitive hybridization model predicts probe signal intensity on high density DNA microarrays. Nucleic Acids Res (2008) 1.05
Evaluation of gene expression data generated from expired Affymetrix GeneChip® microarrays using MAQC reference RNA samples. BMC Bioinformatics (2010) 0.92
Establishing a major cause of discrepancy in the calibration of Affymetrix GeneChips. BMC Bioinformatics (2007) 0.89
Washing scaling of GeneChip microarray expression. BMC Bioinformatics (2010) 0.86
Accurate estimates of microarray target concentration from a simple sequence-independent Langmuir model. PLoS One (2010) 0.82
Scanner calibration revisited. BMC Bioinformatics (2010) 0.82
High-resolution epifluorescence and time-of-flight secondary ion mass spectrometry chemical imaging comparisons of single DNA microarray spots. Anal Chem (2012) 0.82
Application of a correlation correction factor in a microarray cross-platform reproducibility study. BMC Bioinformatics (2007) 0.81
A white-box approach to microarray probe response characterization: the BaFL pipeline. BMC Bioinformatics (2009) 0.81
The LO-BaFL method and ALS microarray expression analysis. BMC Bioinformatics (2012) 0.80
A model of binding on DNA microarrays: understanding the combined effect of probe synthesis failure, cross-hybridization, DNA fragmentation and other experimental details of affymetrix arrays. BMC Genomics (2012) 0.79
Microarray Scanner Performance Over a Five-Week Period as Measured With Cy5 and Cy3 Serial Dilution Slides. J Res Natl Inst Stand Technol (2008) 0.79
The Impact of Photobleaching on Microarray Analysis. Biology (Basel) (2015) 0.78
Proceedings of the second annual conference of the MidSouth Computational Biology and Bioinformatics Society. 7-9 October 2004, Little Rock, Arkansas, USA. BMC Bioinformatics (2005) 0.77
Optimization of Cyanine Dye Stability and Analysis of FRET Interaction on DNA Microarrays. Biology (Basel) (2016) 0.75
ArrayInitiative - a tool that simplifies creating custom Affymetrix CDFs. BMC Bioinformatics (2011) 0.75
Characterization and simulation of cDNA microarray spots using a novel mathematical model. BMC Bioinformatics (2007) 0.75
Characterisation and correction of signal fluctuations in successive acquisitions of microarray images. BMC Bioinformatics (2009) 0.75
Was the Scanner Calibration Slide used for its intended purpose? BMC Bioinformatics (2011) 0.75
Proceedings of the Third Annual Conference of the MidSouth Computational Biology and Bioinformatics Society. Introduction. BMC Bioinformatics (2006) 0.75
Modeling Hybridization Kinetics of Gene Probes in a DNA Biochip Using FEMLAB. Microarrays (Basel) (2017) 0.75
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res (2002) 40.03
Microarray data normalization and transformation. Nat Genet (2002) 15.04
An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43
Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res (2002) 6.70
Absolute mRNA concentrations from sequence-specific calibration of oligonucleotide arrays. Nucleic Acids Res (2003) 5.13
Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol (2002) 4.67
Measuring absolute expression with microarrays with a calibrated reference sample and an extended signal intensity range. Proc Natl Acad Sci U S A (2002) 4.44
An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res (2001) 4.16
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93
ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect (2003) 3.39
Modeling of DNA microarray data by using physical properties of hybridization. Proc Natl Acad Sci U S A (2003) 2.95
Expression profiling--best practices for data generation and interpretation in clinical trials. Nat Rev Genet (2004) 2.91
Making and reading microarrays. Nat Genet (1999) 2.81
QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev Mol Diagn (2004) 2.73
Development of public toxicogenomics software for microarray data management and analysis. Mutat Res (2004) 2.29
A study of accuracy and precision in oligonucleotide arrays: extracting more signal at large concentrations. Bioinformatics (2003) 2.16
Statistical design of reverse dye microarrays. Bioinformatics (2003) 1.68
Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction. BMC Genomics (2004) 1.60
Calibration and assessment of channel-specific biases in microarray data with extended dynamical range. BMC Bioinformatics (2004) 1.58
Dye bias correction in dual-labeled cDNA microarray gene expression measurements. Environ Health Perspect (2004) 1.53
Reduction of autofluorescence on DNA microarrays and slide surfaces by treatment with sodium borohydride. Anal Biochem (2003) 1.48
Questions and answers on design of dual-label microarrays for identifying differentially expressed genes. J Natl Cancer Inst (2003) 1.45
Changes in expression level of genes as a function of time of day in the liver of rats. Mutat Res (2004) 1.20
Correcting log ratios for signal saturation in cDNA microarrays. Bioinformatics (2004) 1.05
Identification and removal of contaminating fluorescence from commercial and in-house printed DNA microarrays. Nucleic Acids Res (2003) 1.04
Current themes in microarray experimental design and analysis. Drug Discov Today (2002) 0.85
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol (2006) 8.87
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin. Proc Natl Acad Sci U S A (2005) 5.95
Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol (2006) 5.92
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics (2010) 5.60
Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2005) 5.13
Toward interoperable bioscience data. Nat Genet (2012) 4.72
The External RNA Controls Consortium: a progress report. Nat Methods (2005) 4.24
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93
Gene expression in human embryonic stem cell lines: unique molecular signature. Blood (2003) 3.73
A strategy capitalizing on synergies: the Reporting Structure for Biological Investigation (RSBI) working group. OMICS (2006) 3.51
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect (2003) 3.39
The toxicology of perfluorooctanoate. Crit Rev Toxicol (2004) 3.05
Comparison of methods for estimating the number of true null hypotheses in multiplicity testing. J Biopharm Stat (2003) 2.83
QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev Mol Diagn (2004) 2.73
Evaluation of external RNA controls for the assessment of microarray performance. Nat Biotechnol (2006) 2.59
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics (2008) 2.54
Physics. Learning and scientific reasoning. Science (2009) 2.49
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell (2011) 2.46
3D cell nuclei segmentation based on gradient flow tracking. BMC Cell Biol (2007) 2.41
Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study. Lancet (2012) 2.41
Estimation of false discovery rates in multiple testing: application to gene microarray data. Biometrics (2003) 2.37
Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson (2011) 2.30
Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics (2005) 2.29
Development of public toxicogenomics software for microarray data management and analysis. Mutat Res (2004) 2.29
Brain tissue segmentation based on DTI data. Neuroimage (2007) 2.06
High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology (2013) 2.02
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01
Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol (2009) 2.01